Skip to content

This content is in French.

TyG Index: a new ally against PCOS?

18 septembre 2025

TyG Index: a new ally against PCOS?
By Ana Espino | Published on september 18, 2025 | 3 min read


#PCOS #Endocrinology #Metabolism #TyGIndex
 


Polycystic ovary syndrome (PCOS) is the most common endocrine disorder among women of reproductive age, affecting up to 15–20% of this population. Although it has been extensively studied, its pathophysiological mechanisms remain only partially understood, particularly regarding the metabolic disturbances associated with it. Insulin resistance, present in nearly 75% of affected women, is a central factor in PCOS and its metabolic complications (metabolic syndrome, diabetes, fatty liver disease).  

Sign in to read the rest

Reserved for healthcare professionals, free registration.

Scientific reference

Javidan, A., et al. (2025). The association between triglyceride-glucose index and polycystic ovary syndrome: a systematic review and meta-analysis across different populations. Journal of ovarian research, 18(1), 163

View the source